Drugs to fight new strain of TB
By Anya van Wyk
13 September 2006
A new virulent strain of Tuberculosis (TB) has killed 52 people. South Africa’s Department of Health has purchased new drugs, that will be distributed soon, to save lives from this new strain of TB.
The department of health has signed a deal with pharmaceutical company Aspen to purchase new drugs. The first purchase will be Capreomycin and they are looking into buying Para Amino Salicylic Acid.
The government has, however, warned that there is no guarantee that these drugs will be effective. Patients will have to be closely observed over the next few months to assess the ability of the drugs to cure the new strain.
Dr Tony Moll, who detected the new strain of TB in Durban, told the Mail and Guardian he thinks that a survey should be done across the country to assess just how big the problem is.
13 September 2006
A new virulent strain of Tuberculosis (TB) has killed 52 people. South Africa’s Department of Health has purchased new drugs, that will be distributed soon, to save lives from this new strain of TB.
The department of health has signed a deal with pharmaceutical company Aspen to purchase new drugs. The first purchase will be Capreomycin and they are looking into buying Para Amino Salicylic Acid.
The government has, however, warned that there is no guarantee that these drugs will be effective. Patients will have to be closely observed over the next few months to assess the ability of the drugs to cure the new strain.
Dr Tony Moll, who detected the new strain of TB in Durban, told the Mail and Guardian he thinks that a survey should be done across the country to assess just how big the problem is.
Comments